OxyFile #50
TI: The Use of Ozone-Treated Blood in the Therapy of HIV
Infection and Immune Disease: A Pilot Study of Safety and
Efficiacy
DT: 1991
AU: Gary E. Garber, D. William Cameron, Nanci Hawley-Foss,
Donald Greenway, and Michael E. Shannon
SO: AIDS 1991, 5:981-984
AB: The use of ozone therapy is reported to be effective in a
variety of viral illnesses, including HIV disease. We
performed a phase 1 study of ozone blood treatments in 10
patients in whom no significant toxicity was observed.
Three patients with moderate immunodeficiency showed
improvement in surrogate markers of HIV-associated immune
disease. A phase 2 controlled and randomized double-
blinded study was initiated comparing reinjection of ozone-
treated blood, and reinjection of unprocessed blood for 8
weeks, followed by a 4-week observation period. Ozone had
no significant effect on hematologic, biochemical or
clinical toxicity when compared with placebo. CD4 cell
count, interleukin-2, -interferon, 2-microglobulin,
neopterin and p24 antigen were also unaffected by both
treatment arms. In conclusion, ozone therapy does not
enhance parameters of immune activation nor does it
diminish measureable p24 antigen in HIV-infected
individuals.
Note: It would wise to speak to Dr. Michael Shannon, Director
Medical Operations, Canadian National Defence before you
put too much weight on this study. In Ed McCabe's
"Chronological Ozone Medical References" and "O3 vs AIDS",
Mr. McCabe wrote, "Poorly designed because the study only
gave 10 cc's of ozone into a muscle (dismissed by Aubourg
in 1938 as too painful and ineffective), not I.V., and not
enough to do any good, and not for long enough time
period." "Poorly executed because during the second half
of the too short study, the principals admitted the ozone
machine had broken, and wasn't producing any ozone, yet
they ignored this fact when they wrote up the second phase
of the study!"